Worldwide $3+ Trillion Health Insurance Market Size is Expected to Grow at a CAGR of over 4.4% During 2022-2028 | Vantage Market Research
April 11, 2022 09:17 ET
|
Vantage Market Research
WASHINGTON, April 11, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Health Insurance Market finds that the increase in adoption of data analytics is expediting...
Clearside Biomedical Expands Patent Portfolio in the U.S. and Europe
August 26, 2020 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Astellas Submits New Drug Application in Japan of Roxadustat for The Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis
October 01, 2018 08:00 ET
|
FibroGen, Inc; Astellas Pharma Inc.
TOKYO and SAN FRANCISCO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and FibroGen, Inc. (Nasdaq: FGEN, CEO: Thomas B....
IntelGenx Announces Notice of Grant of European Patent Covering Rizaport® VersaFilm™
June 19, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, June 19, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that the European Patent Office (“EPO”) has issued a...